Navigation Links
A Breakthrough Discovery on Treating Resistant Biofilm Infections Was Presented January 12 at Medtech Showcase in San Francisco
Date:1/13/2016

COLUMBUS, Ohio, Jan. 13, 2016 /PRNewswire/ -- Details regarding a breakthrough medical discovery with tremendous potential for treatment of patients with serious bacterial infections were presented on January 12 to pharmaceutical leaders and public and private investors attending the Medtech Showcase in San Francisco. 

Logo - http://photos.prnewswire.com/prnh/20160112/321484LOGO

Steven Goodman, Ph.D., a member of the Scientific Board for ProclaRx and Associate Professor of Pediatrics at the Ohio State College of Medicine, and Principal Investigator at the Research Institute of Nationwide Children's Hospital, spoke about a new technology developed by ProclaRx, an Ohio-based biotechnology company, to break down and destroy biofilms.  Biofilms are a physical barrier which protect bacteria and prevent antibiotics and the body's immune system from eradicating chronic infections.

Infections with biofilms are associated with indications as those found in advanced wound care, chronic draining ear infections, and CVID sinusitis. They are highly resistant to antibiotics and have a significant ability to evade normal defenses against bacteria. Recurrent infections and antibiotic resistance is a major clinical and public health problem, with bacterial biofilms implicated in more than 80% of infections.

"Dr. Goodman's presentation clearly demonstrated the power of the anti-biofilm technology. This technology is unusual in that it can support both therapeutic as well as medical device products," stated Joseph D. Kittle, Jr., Ph.D., and CEO for ProclaRx.

Founded in 2014, ProclaRx has exclusive worldwide rights to develop and commercialize anti-infective technology from Nationwide Children's Hospital and the University of Southern California. With $5.5 million invested to-date, they are seeking additional financing and strategic partners. Medtech Showcase is part of the Biotech Showcase, one of the healthcare industry's largest annual healthcare investor conferences.   

About ProclaRx  
ProclaRx is a biotechnology company developing innovative therapeutics for patients suffering from serious bacterial infections. ProclaRx has a breakthrough discovery that inhibits and prevents bacterial biofilms. Lead indications include advanced wound care, secretory otitis media and CVID sinusitis. Visit www.proclarx.com or call 949-302-2165 or e-mail info@proclarx.com.

Contact:  Dr. Joseph D. Kittle, Jr. 
CEO, ProclaRx 
949-302-2165  

 


'/>"/>
SOURCE ProclaRx
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Breakthrough Method for Lipid Analysis in Fecal Material Developed; New Understanding of Diseases/Disorders Related to Gut Function Possible
2. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
3. Pressure BioSciences Announces Core Technology Breakthrough
4. Zydus Pioneers a Breakthrough With LIPAGLYN, Indias First NCE to Reach the Market
5. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
6. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
7. AlignMeds Breakthrough Garment Technology Gets a YES from the FDA!
8. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
9. Tisch MS Researchers Announce Breakthrough in Disease Monitoring
10. Facebook and Twitter Drive Frenzy for Breakthrough "Anti-Aging Pill"
11. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... --  Provista, a proven leader in the supply ... power, today announced a new resource area on Provistaco.com ... is the online home for case studies, articles on ... releases, slideshows and events. ... at their fingertips, viewers can also watch short videos ...
(Date:10/4/2017)... South Korea , Oct. 4, 2017  South ... its next-generation CPR training aide "cprCUBE" on Kickstarter. The ... chest compression during cardiac arrests with better efficiency compared ... It also offers real-time feedback on efficacy of the ... The crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology:
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):